Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III maintenance trial of Monofer vs Venofer in CKD-5D dialysis patients
2010-023471-26Phase 3Completed
- Sponsor
- Pharmacosmos
- Start
- Jan 2011
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ferric derisomaltose in anemia of renal disease, chronic kidney disease (CKD) and end-stage kidney disease (ESKD) (2 arms), sponsored by Pharmacosmos. Started Jan 2011; status: completed.
02
Drugs
ferric derisomaltose
03
Conditions
anemia of renal diseasechronic kidney disease (CKD)end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on 2010-023471-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023471-26.